Citations (74)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
George E Fragoulis, Stergios Soulaidopoulos, Petros P Sfikakis, Theodoros Dimitroulas & George D Kitas. (2021) Effect of Biologics on Cardiovascular Inflammation: Mechanistic Insights and Risk Reduction. Journal of Inflammation Research 14, pages 1915-1931.
Read now
Read now
George A Karpouzas, Viet L Bui, Nicoletta Ronda, Ivana Hollan & Sarah R Ormseth. (2021) Biologics and atherosclerotic cardiovascular risk in rheumatoid arthritis: a review of evidence and mechanistic insights. Expert Review of Clinical Immunology 17:4, pages 355-374.
Read now
Read now
Maurizio Benucci, Francesca Bandinelli, Arianna Damiani, Francesca Li Gobbi, Maria Infantino, Valentina Grossi & Mariangela Manfredi. (2018) Factors correlated with the improvement of endothelial dysfunction during Abatacept therapy in patients with rheumatoid arthritis. Journal of Inflammation Research 11, pages 247-252.
Read now
Read now
Katharina Urschel & Iwona Cicha. (2015) TNF-α in the cardiovascular system: from physiology to therapy. International Journal of Interferon, Cytokine and Mediator Research 7, pages 9-25.
Read now
Read now
L-S Tam, EK Li, Q Shang, B Tomlinson, VW Lee, KK Lee, M Li, W Pang Kuan, TK Li, L Tseung, GWK Yip, B Freedman & C-M Yu. (2011) Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial. Scandinavian Journal of Rheumatology 40:6, pages 411-421.
Read now
Read now
A Nakajima, E Inoue, E Tanaka, G Singh, E Sato, D Hoshi, K Shidara, M Hara, S Momohara, A Taniguchi, N Kamatani & H Yamanaka. (2010) Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA. Scandinavian Journal of Rheumatology 39:5, pages 360-367.
Read now
Read now
Pierpaolo Di Micco, Paola Ferrazzi, Luca Librè, Loredana Mendolicchio, Ilaria Quaglia, Monica De Marco, Anna Colombo, Monica Bacci, Lidia Luciana Rota & Corrado Lodigiani. (2009) Intima-media thickness evolution after treatment with infliximab in patients with rheumatoid arthritis. International Journal of General Medicine 2, pages 141-144.
Read now
Read now
Articles from other publishers (67)
Georgi Gerganov, Tsvetoslav Georgiev, Maria Dimova & Tanya Shivacheva. (2023) Vascular effects of biologic and targeted synthetic antirheumatic drugs approved for rheumatoid arthritis: a systematic review. Clinical Rheumatology 42:10, pages 2651-2676.
Crossref
Crossref
Bafrin Abdulmajid, Annelies B. Blanken, Eva H. van Geel, Joost G. Daams & Michael T. Nurmohamed. (2023) Effect of TNF inhibitors on arterial stiffness and intima media thickness in rheumatoid arthritis: a systematic review and meta-analysis. Clinical Rheumatology 42:4, pages 999-1011.
Crossref
Crossref
Mohammad Abu-Abaa, Ghassan Al-Qaysi, Ahmed Hassan & Salman Kananeh. (2023) Subarachnoid Hemorrhage With Multifocal Cerebral Aneurysms in a Patient With Crohn’s Disease and Sjögren's Syndrome: A Case Report and Literature Review. Cureus.
Crossref
Crossref
Sulè Gunter, Frederic S. Michel, Serena S. Fourie, Mikayra Singh, Regina le Roux, Ashmeetha Manilall, Lebogang P. Mokotedi & Aletta M. E. Millen. (2022) The effect of TNF-α inhibitor treatment on microRNAs and endothelial function in collagen induced arthritis. PLOS ONE 17:2, pages e0264558.
Crossref
Crossref
Vincenzo Restivo, Stefania Candiloro, Mario Daidone, Rosario Norrito, Marco Cataldi, Giuseppa Minutolo, Francesca Caracci, Serena Fasano, Francesco Ciccia, Alessandra Casuccio & Antonino Tuttolomondo. (2022) Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: Symptomatic and non-symptomatic events in rheumatoid arthritis and systemic lupus erythematosus. Autoimmunity Reviews 21:1, pages 102925.
Crossref
Crossref
Marta Rojas-Giménez, Clementina López-Medina, Jerusalem Calvo-Gutiérrez, María Ángeles Puche-Larrubia, Ignacio Gómez-García, Pedro Seguí-Azpilcueta, María del Carmen Ábalos-Aguilera, Desirée Ruíz, Eduardo Collantes-Estévez & Alejandro Escudero-Contreras. (2021) Association between Carotid Intima-Media Thickness and the Use of Biological or Small Molecule Therapies in Patients with Rheumatoid Arthritis. Diagnostics 12:1, pages 64.
Crossref
Crossref
Brittany N. Weber, Emma Stevens, Lourdes M. Perez-Chada, Jenifer M. Brown, Sanjay Divakaran, Camden Bay, Courtney Bibbo, Jon Hainer, Sharmila Dorbala, Ron Blankstein, Viviany R. Taqueti, Joseph F. Merola, Elena Massarotti, Karen Costenbader, Katherine Liao & Marcelo F. Di Carli. (2021) Impaired Coronary Vasodilator Reserve and Adverse Prognosis in Patients With Systemic Inflammatory Disorders. JACC: Cardiovascular Imaging 14:11, pages 2212-2220.
Crossref
Crossref
Maria Drakopoulou, Stergios Soulaidopoulos, George Oikonomou, Dimitrios Tousoulis & Konstantinos Toutouzas. (2020) Cardiovascular Effects of Biologic Disease-Modifying Anti-Rheumatic Drugs (DMARDs). Current Vascular Pharmacology 18:5, pages 488-506.
Crossref
Crossref
Laurence Knowles, Nida Nadeem & Philip J. Chowienczyk. (2020) Do anti‐tumour necrosis factor‐α biologics affect subclinical measures of atherosclerosis and arteriosclerosis? A systematic review. British Journal of Clinical Pharmacology 86:5, pages 837-851.
Crossref
Crossref
Daniel J. DeMizio & Laura B. Geraldino-Pardilla. (2019) Autoimmunity and Inflammation Link to Cardiovascular Disease Risk in Rheumatoid Arthritis. Rheumatology and Therapy 7:1, pages 19-33.
Crossref
Crossref
Edit Végh, György Kerekes, Anita Pusztai, Attila Hamar, Szilvia Szamosi, Andrea Váncsa, Levente Bodoki, Lilla Pogácsás, Fruzsina Balázs, Katalin Hodosi, Andrea Domján, Sándor Szántó, Zoltán Nagy, Zoltán Szekanecz & Gabriella Szűcs. (2019) Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis. Rheumatology International 40:3, pages 427-436.
Crossref
Crossref
Feng Yao, Guangde Yang, Yushan Xian, Guan Wang, Zihan Zheng, Zhen Jin, Yundong Xie, Weirong Wang, Jianli Gu & Rong Lin. (2019) The protective effect of hydroxytyrosol acetate against inflammation of vascular endothelial cells partly through the SIRT6-mediated PKM2 signaling pathway. Food & Function 10:9, pages 5789-5803.
Crossref
Crossref
Isabelle AmiguesCesare RussoJon T. GilesAylin TugcuRichard WeinbergSabahat BokhariJoan M. Bathon. (2019) Myocardial Microvascular Dysfunction in Rheumatoid Arthritis. Circulation: Cardiovascular Imaging 12:1.
Crossref
Crossref
Cristina Panico & Gianluigi Condorelli. (2017) Unmet Needs in the Pathogenesis and Treatment of Cardiovascular Comorbidities in Chronic Inflammatory Diseases. Clinical Reviews in Allergy & Immunology 55:3, pages 254-270.
Crossref
Crossref
Ntobeko A.B. Ntusi, Jane M. Francis, Emily Sever, Alexander Liu, Stefan K. Piechnik, Vanessa M. Ferreira, Paul M. Matthews, Matthew D. Robson, Paul B. Wordsworth, Stefan Neubauer & Theodoros D. Karamitsos. (2018) Anti-TNF modulation reduces myocardial inflammation and improves cardiovascular function in systemic rheumatic diseases. International Journal of Cardiology 270, pages 253-259.
Crossref
Crossref
Luca Moroni, Carlo Selmi, Claudio Angelini & Pier Luigi Meroni. (2017) Evaluation of Endothelial Function by Flow-Mediated Dilation: a Comprehensive Review in Rheumatic Disease. Archivum Immunologiae et Therapiae Experimentalis 65:6, pages 463-475.
Crossref
Crossref
Francesco Ursini, Christian Leporini, Fabiola Bene, Salvatore D’Angelo, Daniele Mauro, Emilio Russo, Giovambattista De Sarro, Ignazio Olivieri, Costantino Pitzalis, Myles Lewis & Rosa Daniela Grembiale. (2017) Anti-TNF-alpha agents and endothelial function in rheumatoid arthritis: a systematic review and meta-analysis. Scientific Reports 7:1.
Crossref
Crossref
Z. Szekanecz. 2017. The Heart in Systemic Autoimmune Diseases. The Heart in Systemic Autoimmune Diseases
489
529
.
M. Turiel, L. Gianturco, F. Atzeni, P. Sarzi-Puttini, M. Porcu & M. Corda. 2017. The Heart in Systemic Autoimmune Diseases. The Heart in Systemic Autoimmune Diseases
183
207
.
Jenny Humphreys, Kimme Hyrich & Deborah Symmons. (2016) What is the impact of biologic therapies on common co-morbidities in patients with rheumatoid arthritis?. Arthritis Research & Therapy 18:1.
Crossref
Crossref
Raghav Oberoi, Jutta Schuett, Harald Schuett, Ann-Kathrin Koch, Maren Luchtefeld, Karsten Grote & Bernhard Schieffer. (2016) Targeting Tumor Necrosis Factor-α with Adalimumab: Effects on Endothelial Activation and Monocyte Adhesion. PLOS ONE 11:7, pages e0160145.
Crossref
Crossref
Perle Totoson, Katy Maguin-Gaté, Anne Prigent-Tessier, Alice Monnier, Frank Verhoeven, Christine Marie, Daniel Wendling & Céline Demougeot. (2016) Etanercept improves endothelial function via pleiotropic effects in rat adjuvant-induced arthritis. Rheumatology 55:7, pages 1308-1317.
Crossref
Crossref
Zoltán Szekanecz, György Kerekes, Edit Végh, Zsófia Kardos, Zsuzsa Baráth, László Tamási & Yehuda Shoenfeld. (2016) Autoimmune atherosclerosis in 3D: How it develops, how to diagnose and what to do. Autoimmunity Reviews 15:7, pages 756-769.
Crossref
Crossref
Haifang Wang, Jinlian Liu, Yuejin Yang, Qingwen Cao, Xueping Huo, Shuhui Ma, Jun Hu, Fredrick M. Pavalko & Qinshe Liu. (2016) Hydroxy‐Safflower Yellow A inhibits the TNFR1‐Mediated Classical NF‐κB Pathway by Inducing Shedding of TNFR1. Phytotherapy Research 30:5, pages 790-796.
Crossref
Crossref
Jiayun Shen, Qing Shang & Lai-Shan Tam. (2016) Targeting inflammation in the prevention of cardiovascular disease in patients with inflammatory arthritis. Translational Research 167:1, pages 138-151.
Crossref
Crossref
Alicia M. Zha, Mario Di Napoli & Réza Behrouz. (2015) Prevention of Stroke in Rheumatoid Arthritis. Current Neurology and Neuroscience Reports 15:12.
Crossref
Crossref
Ygal Benhamou, Sébastien Miranda, Guillaume Armengol, Najah Harouki, Laurent Drouot, Noel Zahr, Christian Thuillez, Olivier Boyer, Hervé Levesque, Robinson Joannides & Vincent Richard. (2015) Infliximab improves endothelial dysfunction in a mouse model of antiphospholipid syndrome: Role of reduced oxidative stress. Vascular Pharmacology 71, pages 93-101.
Crossref
Crossref
Perle Totoson, Katy Maguin‐Gaté, Maude Nappey, Clément Prati, Daniel Wendling & Céline Demougeot. (2015) Microvascular Abnormalities in Adjuvant‐Induced Arthritis: Relationship to Macrovascular Endothelial Function and Markers of Endothelial Activation. Arthritis & Rheumatology 67:5, pages 1203-1213.
Crossref
Crossref
Debbie T. Lim, Amy C. Cannella, Kaleb D Michaud & Ted R. Mikuls. (2014) Cardiovascular Risk and the Use of Biologic Agents in Rheumatoid Arthritis. Current Rheumatology Reports 16:11.
Crossref
Crossref
Clément Prati, Céline Demougeot, Xavier Guillot, Marie Godfrin-Valnet & Daniel Wendling. (2014) Dysfonction endothéliale et rhumatisme. Revue du Rhumatisme 81:5, pages 362-367.
Crossref
Crossref
Clément Prati, Céline Demougeot, Xavier Guillot, Marie Godfrin-Valnet & Daniel Wendling. (2014) Endothelial dysfunction in joint disease. Joint Bone Spine 81:5, pages 386-391.
Crossref
Crossref
Y. Benhamou, J. Bellien, G. Armengol, E. Gomez, V. Richard, H. Lévesque & R. Joannidès. (2014) Évaluation de la fonction endothéliale au cours des maladies auto-immunes. La Revue de Médecine Interne 35:8, pages 512-523.
Crossref
Crossref
Curtis SteyersIIIIII & Francis MillerJr.Jr.. (2014) Endothelial Dysfunction in Chronic Inflammatory Diseases. International Journal of Molecular Sciences 15:7, pages 11324-11349.
Crossref
Crossref
L.-S. Tam, Q. Shang, E. W. Kun, K.-L. Lee, M.-L. Yip, M. Li, T. K. Li, T. Y. Zhu, M. O. Pui, E. K. Li & C.-M. Yu. (2014) The effects of golimumab on subclinical atherosclerosis and arterial stiffness in ankylosing spondylitis--a randomized, placebo-controlled pilot trial. Rheumatology 53:6, pages 1065-1074.
Crossref
Crossref
L.-S. Tam, G. D. Kitas & M. A. Gonzalez-Gay. (2014) Can suppression of inflammation by anti-TNF prevent progression of subclinical atherosclerosis in inflammatory arthritis?. Rheumatology 53:6, pages 1108-1119.
Crossref
Crossref
Antongiulio Scarno. (2014) Beyond the joint: Subclinical atherosclerosis in rheumatoid arthritis. World Journal of Orthopedics 5:3, pages 328.
Crossref
Crossref
Paola Gargiulo, Fabio Marsico, Antonio Parente, Stefania Paolillo, Milena Cecere, Laura Casaretti, Angela Maria Pellegrino, Tiziana Formisano, Irma Fabiani, Andrea Soricelli, Bruno Trimarco & Pasquale Perrone-Filardi. (2014) Ischemic heart disease in systemic inflammatory diseases. An appraisal. International Journal of Cardiology 170:3, pages 286-290.
Crossref
Crossref
Roberta Ramonda, Valentina Modesti, Augusta Ortolan, Anna Scanu, Nicola Bassi, Francesca Oliviero & Leonardo Punzi. (2013) Serological markers in psoriatic arthritis: promising tools. Experimental Biology and Medicine 238:12, pages 1431-1436.
Crossref
Crossref
Selvinaz Dalaklioglu, Arda Tasatargil, Sule Kale, Gamze Tanriover, Sayra Dilmac & Nuray Erin. (2013) Metastatic breast carcinoma induces vascular endothelial dysfunction in Balb-c mice: Role of the tumor necrosis factor-α and NADPH oxidase. Vascular Pharmacology 59:3-4, pages 103-111.
Crossref
Crossref
Aamer Sandoo, James Hodson, Karen M Douglas, Jacqueline P Smith & George D Kitas. (2013) The association between functional and morphological assessments of endothelial function in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Research & Therapy 15:5, pages R107.
Crossref
Crossref
LAI-SHAN TAM, QING SHANG, EDMUND K. LI, SHANG WANG, RUI-JIE LI, KA-LAI LEE, YING-YING LEUNG, KING-YEE YING, CHEUK-WAN YIM, EMILY W. KUN, MOON-HO LEUNG, MARTIN LI, TENA K. LI, TRACY Y. ZHU, RICKY K. CHUI, LORRAINE TSEUNG, SHUI-LIAN YU, WOON-PANG KUAN & CHEUK-MAN YU. (2012) Infliximab is Associated with Improvement in Arterial Stiffness in Patients with Early Rheumatoid Arthritis — A Randomized Trial. The Journal of Rheumatology 39:12, pages 2267-2275.
Crossref
Crossref
Eugenia Gkaliagkousi, Eleni Gavriilaki, Michael Doumas, Konstantinos Petidis, Spyros Aslanidis & Douma Stella. (2012) Cardiovascular Risk in Rheumatoid Arthritis. Journal of Clinical Rheumatology 18:8, pages 422-430.
Crossref
Crossref
Bruce E. Strober, Jennifer Clay Cather, David Cohen, Jeffrey J. Crowley, Kenneth B. Gordon, Alice B. Gottlieb, Arthur F. Kavanaugh, Neil J. Korman, Gerald G. Krueger, Craig L. Leonardi, Sergio Schwartzman, Jeffrey M. Sobell, Gary E. Solomon & Melodie Young. (2012) A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 1. Dermatology and Therapy 2:1.
Crossref
Crossref
Aamer Sandoo, Theodoros Dimitroulas, Tracey E. Toms, James Hodson, Jet J.C.S. Veldhuijzen van Zanten, Jacqueline P. Smith & George D. Kitas. (2012) Clinical remission following treatment with tumour necrosis factor-alpha antagonists is not accompanied by changes in asymmetric dimethylarginine in patients with rheumatoid arthritis. Clinical Biochemistry 45:16-17, pages 1399-1403.
Crossref
Crossref
Kristin Angel, Sella A. Provan, Magne K. Fagerhol, Petter Mowinckel, Tore K. Kvien & Dan Atar. (2012) Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study. American Journal of Hypertension 25:6, pages 644-650.
Crossref
Crossref
PRZEMYSLAW J. KOTYLA, ALEKSANDER OWCZAREK, JAROSLAW RAKOCZY, MACIEJ LEWICKI, EUGENE J. KUCHARZ & PAUL EMERY. (2012) Infliximab Treatment Increases Left Ventricular Ejection Fraction in Patients with Rheumatoid Arthritis: Assessment of Heart Function by Echocardiography, Endothelin 1, Interleukin 6, and NT-pro Brain Natriuretic Peptide. The Journal of Rheumatology 39:4, pages 701-706.
Crossref
Crossref
György Kerekes, Pál Soltész, Michael T. Nurmohamed, Miguel A. Gonzalez-Gay, Maurizio Turiel, Edit Végh, Yehuda Shoenfeld, Iain McInnes & Zoltán Szekanecz. (2012) Validated methods for assessment of subclinical atherosclerosis in rheumatology. Nature Reviews Rheumatology 8:4, pages 224-234.
Crossref
Crossref
Takuya Kotani, Tohru Takeuchi, Shinji Takai, Shuzo Yoshida, Kenichiro Hata, Koji Nagai, Daisuke Wakura, Kentaro Isoda, Shigeki Makino & Toshiaki Hanafusa. (2012) Serum Levels of Matrix Metalloproteinase (MMP) 9, a Risk Factor for Acute Coronary Syndrome, Are Reduced Independently of Serum MMP-3 by Anti-TNF-^|^alpha; Antibody (Infliximab) Therapy in Patients With Rheumatoid Arthritis. Journal of Pharmacological Sciences 120:1, pages 50-53.
Crossref
Crossref
Aamer Sandoo, George D Kitas, Douglas Carroll & Jet JCS Veldhuijzen van Zanten. (2012) The role of inflammation and cardiovascular disease risk on microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional and longitudinal study. Arthritis Research & Therapy 14:3, pages R117.
Crossref
Crossref
Carlos Gonzalez-Juanatey, Tomas R. Vazquez-Rodriguez, Jose A. Miranda-Filloy, Ines Gomez-Acebo, Ana Testa, Carlos Garcia-Porrua, Amalia Sanchez-Andrade, Javier Llorca & Miguel A. González-Gay. (2012) Anti-TNF-Alpha-Adalimumab Therapy Is Associated with Persistent Improvement of Endothelial Function without Progression of Carotid Intima-Media Wall Thickness in Patients with Rheumatoid Arthritis Refractory to Conventional Therapy. Mediators of Inflammation 2012, pages 1-8.
Crossref
Crossref
Zoltán Szekanecz, György Kerekes & Yehuda Shoenfeld. 2012. Inflammation and Atherosclerosis. Inflammation and Atherosclerosis
513
528
.
Lotta Ljung, Julia F. Simard, Lennart Jacobsson, Solbritt Rantapää‐Dahlqvist & Johan Askling. (2011) Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis. Arthritis & Rheumatism 64:1, pages 42-52.
Crossref
Crossref
Victoria Furer, Zahi A. Fayad, Michael E. Farkouh, David Rosenbaum & Jeffrey D. Greenberg. (2011) Noninvasive atherosclerosis imaging modalities and their application to investigating cardiovascular drug effects in rheumatoid arthritis. Drug Development Research 72:8, pages 739-749.
Crossref
Crossref
Aamer Sandoo, Jet J. C. S. Veldhuijzen van Zanten, George S. Metsios, Douglas Carroll & George D. Kitas. (2011) Vascular function and morphology in rheumatoid arthritis: a systematic review. Rheumatology 50:11, pages 2125-2139.
Crossref
Crossref
Pál Soltész, György Kerekes, Henriett Dér, Gabriella Szücs, Sándor Szántó, Emese Kiss, Edit Bodolay, Margit Zeher, Orsolya Timár, Péter Szodoray, Gyula Szegedi & Zoltán Szekanecz. (2011) Comparative assessment of vascular function in autoimmune rheumatic diseases: Considerations of prevention and treatment. Autoimmunity Reviews 10:7, pages 416-425.
Crossref
Crossref
Henry R. Kramer & Jon T. Giles. (2011) Cardiovascular disease risk in rheumatoid arthritis: Progress, debate, and opportunity. Arthritis Care & Research 63:4, pages 484-499.
Crossref
Crossref
Cheryl Barnabe, Billie‐Jean Martin & William A. Ghali. (2011) Systematic review and meta‐analysis: Anti–tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis. Arthritis Care & Research 63:4, pages 522-529.
Crossref
Crossref
Margarita Carlos & Melanie Ortleb. (2018) Treatment with Tumor Necrosis Factor Antagonists and Their Possible Effects on Morbidity and Mortality in Psoriasis Patients. Psoriasis Forum 17a:1, pages 56-62.
Crossref
Crossref
Carlos González-Juanatey, Javier Llorca & Miguel A González-Gay. (2011) Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease. Arthritis Research & Therapy 13:3, pages R101.
Crossref
Crossref
Fabiola Atzeni, Maurizio Turiel, Roberto Caporali, Lorenzo Cavagna, Livio Tomasoni, Simona Sitia & Piercarlo Sarzi-Puttini. (2010) The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases. Autoimmunity Reviews 9:12, pages 835-839.
Crossref
Crossref
Zoltán Szekanecz, Sándor Szántó, Zoltán Szabó, Andrea Váncsa, Szilvia Szamosi, Nóra Bodnár & Gabriella Szücs. (2010) Biologics — beyond the joints. Autoimmunity Reviews 9:12, pages 820-824.
Crossref
Crossref
I.H. Tarner, U. Müller-Ladner & C. Hamm. (2010) Biologika und kardiovaskuläres RisikoBiologics and cardiovascular risk. Zeitschrift für Rheumatologie 69:8, pages 702-711.
Crossref
Crossref
Faisel KHAN. (2010) Assessment of endothelial function as a marker of cardiovascular risk in patients with rheumatoid arthritis. International Journal of Rheumatic Diseases 13:3, pages 189-195.
Crossref
Crossref
Elena Myasoedova & Sherine E Gabriel. (2010) Cardiovascular disease in rheumatoid arthritis: a step forward. Current Opinion in Rheumatology 22:3, pages 342-347.
Crossref
Crossref
Faisel Khan, Bernat Galarraga & Jill J. F. Belch. (2010) The role of endothelial function and its assessment in rheumatoid arthritis. Nature Reviews Rheumatology 6:5, pages 253-261.
Crossref
Crossref
Mariana J. Kaplan. (2010) Cardiovascular Complications of Rheumatoid Arthritis: Assessment, Prevention, and Treatment. Rheumatic Disease Clinics of North America 36:2, pages 405-426.
Crossref
Crossref
Zoltán Szekanecz, György Kerekes & Pál Soltész. (2009) Vascular effects of biologic agents in RA and spondyloarthropathies. Nature Reviews Rheumatology 5:12, pages 677-684.
Crossref
Crossref